BRAF and alkaline phosphatase measurement: The prevalence of combinations of KIAA1549‐BRAF was 24 (75%), accompanied by BRAF V600E and histone H3.3 K27M tests to identify links between these subatomic characteristics and clinical features in a companion group of 32 patients with AP.